Richard P Slaughter Associates Inc grew its position in shares of JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) by 18.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 313,383 shares of the company’s stock after purchasing an additional 49,629 shares during the period. JPMorgan International Research Enhanced Equity ETF comprises about 4.1% of Richard P Slaughter Associates Inc’s holdings, making the stock its 5th largest holding. Richard P Slaughter Associates Inc owned approximately 0.31% of JPMorgan International Research Enhanced Equity ETF worth $18,336,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. FMR LLC grew its holdings in shares of JPMorgan International Research Enhanced Equity ETF by 34.6% during the 3rd quarter. FMR LLC now owns 12,172,036 shares of the company’s stock valued at $803,720,000 after purchasing an additional 3,127,580 shares during the last quarter. LPL Financial LLC grew its stake in shares of JPMorgan International Research Enhanced Equity ETF by 21.5% during the third quarter. LPL Financial LLC now owns 2,776,806 shares of the company’s stock valued at $183,353,000 after buying an additional 492,080 shares during the last quarter. Janney Montgomery Scott LLC increased its holdings in shares of JPMorgan International Research Enhanced Equity ETF by 4.4% in the third quarter. Janney Montgomery Scott LLC now owns 1,189,305 shares of the company’s stock worth $78,530,000 after buying an additional 49,694 shares during the period. Commonwealth Equity Services LLC lifted its stake in shares of JPMorgan International Research Enhanced Equity ETF by 13.6% in the 3rd quarter. Commonwealth Equity Services LLC now owns 1,126,247 shares of the company’s stock valued at $74,366,000 after acquiring an additional 135,261 shares during the last quarter. Finally, Parcion Private Wealth LLC lifted its stake in shares of JPMorgan International Research Enhanced Equity ETF by 13.2% in the 3rd quarter. Parcion Private Wealth LLC now owns 1,008,717 shares of the company’s stock valued at $66,606,000 after acquiring an additional 117,790 shares during the last quarter.
JPMorgan International Research Enhanced Equity ETF Price Performance
JIRE opened at $58.30 on Wednesday. The stock’s 50 day simple moving average is $60.74 and its 200 day simple moving average is $62.91. The firm has a market cap of $5.82 billion, a price-to-earnings ratio of 16.01 and a beta of 0.84. JPMorgan International Research Enhanced Equity ETF has a 1 year low of $56.46 and a 1 year high of $67.10.
About JPMorgan International Research Enhanced Equity ETF
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Read More
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- The 3 Best Retail Stocks to Shop for in August
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Can Integrated Healthcare Stocks Succeed in Public Markets?
- What is the Nasdaq? Complete Overview with History
- What Lucid’s Partnership With SoundHound Means for LCID Stock
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.